Author:
Wei L,Qu W,Sun J,Wang X,Lv L,Xie L,Song X
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology,Molecular Medicine
Reference31 articles.
1. Saintigny P, Burger JA . Recent advances in non-small cell lung cancer biology and clinical management. Discov Med 2012; 13: 287–297.
2. Tassinari D, Carloni F, Santelmo C, Tamburini E, Lazzari Agli L, Tombesi P et al. Second line treatments in advanced platinum-resistant non small cell lung cancer. A critical review of literature. Rev Recent Clin Trials 2009; 4: 27–33.
3. Brognard J, Clark AS, Ni Y, Dennis PA . Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res 2001; 61: 3986–3997.
4. David O, Jett J, LeBeau H, Dy G, Hughes J, Friedman M et al. Phospho-Akt overexpression in non-small cell lung cancer confers significant stage independent survival disadvantage. Clin Cancer Res 2004; 10: 6865–6871.
5. Chen KF, Liu CY, Lin YC, Yu HC, Liu TH, Hou DR et al. CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells. Oncogene 2010; 29: 6257–6266.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献